Galapagos M&A Summary
Galapagos has acquired 9 companies, including 2 in the last 5 years. It has also divested 4 assets.
Galapagos’ largest acquisition to date was in 2008, when it acquired Sareum Holdings - Drug Discovery business for $783M. It’s largest disclosed sale occurred in 2014, when it sold Galapagos NV - CRO Services Division to Charles River Laboratories International for $145M. Galapagos has acquired in 2 different US states, and 5 countries. The Company’s most targeted sectors include life science (89%) and information technology (12%).
M&A Summary
-
M&A Total Activity13
- M&A Buy Activity9
- M&A Sell Activity4
- Total Sectors Invested 2
- Total Countries Invested 5
- M&A Buy/Sell Connections 6